ARTHROPLASTY
Topical TXA reduces blood loss compared to IV TXA in bilateral total knee arthroplasty
J Arthroplasty. 2016 Jul;31(7):1442-870 patients scheduled for simultaneous bilateral total knee arthroplasty were randomized to administration of intravenous or topical tranexamic acid. The purpose of this study was to compare, primarily, haemostatic efficacy and safety between the two groups, perioperatively, as well as clinical outcomes at follow-up. The results of this trial demonstrated that the estimated total blood loss, postoperative blood drainage, and the incidence of transfusion were significantly lower in the topical TXA group compared to the IV TXA group. Clinical outcomes favoured the topical TXA group; however, these differences were no likely to be clinically significant.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
